phenidone has been researched along with Goldblatt Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eggena, P; Golub, M; Nadler, JL; Nozawa, K; Stern, N; Tuck, ML | 1 |
| Eggena, P; Golub, M; Nadler, J; Nozawa, K; Stern, N; Tuck, ML | 1 |
2 other study(ies) available for phenidone and Goldblatt Syndrome
| Article | Year |
|---|---|
Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Aorta; Blood Pressure; Hydroxyeicosatetraenoic Acids; Hypertension, Renovascular; Lipoxygenase Inhibitors; Male; Pyrazoles; Rats; Rats, Inbred Strains; Time Factors | 1990 |
Hypotensive effects of the lipoxygenase inhibitor phenidone in two-kidney, one clip Goldblatt hypertension.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Hypertension, Renovascular; Lipoxygenase Inhibitors; Male; Pyrazoles; Rats; Rats, Inbred Strains; Renin | 1989 |